Semtech plans to acquire Gennum
Semiconductor company Semtech Corp said on Monday that it plans to acquire Canadian company Gennum Corp for about C$500 million.
Sanofi-aventis and Genzyme Corporation announced today that they have entered into a definitive agreement under which sanofi-aventis is to acquire Genzyme for $74.00 per share in cash, or approximately $20.1 billion.